Detalhe da pesquisa
1.
Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trial.
Cancer Sci
; 114(9): 3698-3707, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434391
2.
Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
J Gastroenterol Hepatol
; 37(7): 1275-1283, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35342997
3.
Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
Int J Clin Oncol
; 27(12): 1828-1838, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036294
4.
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.
BMC Womens Health
; 21(1): 250, 2021 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154590
5.
Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.
BMC Womens Health
; 21(1): 375, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711224
6.
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
Int J Clin Oncol
; 28(5): 724-725, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648711
7.
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
Int J Clin Oncol
; 27(12): 1839-1840, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36243793
8.
Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan.
Jpn J Clin Oncol
; 45(12): 1168-74, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486824
9.
Evaluating the Safety, Tolerability, and Disposition of Trazpiroben, a D2 /D3 Receptor Antagonist: Phase I Single- and Multiple-Ascending Dose Studies in Healthy Japanese Participants.
Clin Pharmacol Drug Dev
; 11(6): 695-706, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967147
10.
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study.
Fertil Steril
; 115(2): 397-405, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32912633
11.
Brigatinib in Japanese Patients With ALK-Positive NSCLC Previously Treated With Alectinib and Other Tyrosine Kinase Inhibitors: Outcomes of the Phase 2 J-ALTA Trial.
J Thorac Oncol
; 16(3): 452-463, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248320
12.
Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.
Fertil Steril
; 112(5): 922-929.e2, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31594635
13.
Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
Obstet Gynecol
; 133(3): 423-433, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741797
14.
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.
World J Gastroenterol
; 24(14): 1550-1561, 2018 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29662293
15.
Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study.
Cardiovasc Ther
; 33(6): 317-23, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222126
16.
Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study.
J Clin Lipidol
; 7(6): 615-25, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24314359
17.
Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized double-blind (ORD) study.
J Clin Lipidol
; 7(3): 199-207, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23725919